E-drug: Australian Prescriber Vol 22 No 4
-----------------------------------------
Dear E-drug colleagues:
Australian Prescriber Vol 22 No 4 (August 1999) is now available, both as
hard copy and on our web site at www.australianprescriber.com
A list of contents is as follows
Advertising pharmaceuticals to Australians (editorial) - J. Donovan
Letters
The Australian Pharmaceutical Manufacturers Association Code of Conduct:
guiding the promotion of prescription medicines - E.E. Roughead
Complaints: a personal view
New antipsychotic medications - J.McGrath & P. White
Patient support organisations
Stroke in the era of evidence-based medicine: Australian comment - E.G.
Stewart-Wynne
Oral extended-release products - L.N. Sansom
Abnormal laboratory results: Hepatitis C: diagnosis and monitoring -
D.J. Siebert, A.M. Breschkin, D.S. Bowden & S.A. Locarnini
New drugs
Your questions to the PBAC
Any health professional who wishes to be added to the mailing list should
email to:
info@australianprescriber.com
or write to:
Australian Prescriber Mailing Service
GPO Box 1909
CANBERRA ACT 2601
AUSTRALIA
Please note that details of the person's profession should accompany
requests.
Thanks
Susan Reid
for Dr John Dowden
Editor - Australian Prescriber
Email: Susan.Reid@health.gov.au [added manually, WB]
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.